Charles A. Rowland Jr

Insider Reports History

Entity
Individual
Location
3338 Lancashire Rd, Furlong, PA
Signature
/s/ Michael Morneau, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles A. Rowland Jr:

Insider Reports Filed by Charles A. Rowland Jr

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VKTX Viking Therapeutics, Inc. Jan 2, 2025 1 $0 4 Jan 6, 2025 Director
GBIO Generation Bio Co. Jun 6, 2024 1 $0 4 Jun 10, 2024 Director
ORTX Orchard Therapeutics plc Jan 24, 2024 3 $0 4 Jan 24, 2024 Director
VKTX Viking Therapeutics, Inc. Jan 2, 2024 1 $0 4 Jan 4, 2024 Director
GBIO Generation Bio Co. Dec 1, 2023 2 $478K 4 Dec 5, 2023 Director
ORTX Orchard Therapeutics plc Jun 14, 2023 1 $0 4 Jun 16, 2023 Director
GBIO Generation Bio Co. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
VKTX Viking Therapeutics, Inc. May 16, 2023 3 -$957K 4 May 18, 2023 Director
VKTX Viking Therapeutics, Inc. Jan 3, 2023 1 $0 4 Jan 4, 2023 Director
GBIO Generation Bio Co. Sep 19, 2022 1 $82.8K 4 Sep 20, 2022 Director
GBIO Generation Bio Co. Sep 15, 2022 2 $276K 4 Sep 19, 2022 Director
GBIO Generation Bio Co. Sep 13, 2022 2 $127K 4 Sep 15, 2022 Director
GBIO Generation Bio Co. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
ORTX Orchard Therapeutics plc Jun 7, 2022 1 $0 4 Jun 8, 2022 Director
VKTX Viking Therapeutics, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
NBRV Nabriva Therapeutics plc Aug 2, 2021 1 -$932 4 Aug 4, 2021 Director
NBRV Nabriva Therapeutics plc Jul 28, 2021 2 $0 4 Jul 30, 2021 Director
ORTX Orchard Therapeutics plc Jun 16, 2021 1 $0 4 Jun 17, 2021 Director
GBIO Generation Bio Co. Jun 9, 2021 1 $0 4 Jun 11, 2021 Director
BPMC Blueprint Medicines Corp Jun 2, 2021 2 $0 4 Jun 4, 2021 Director
NBRV Nabriva Therapeutics plc Aug 1, 2020 1 -$1.49K 4 Aug 3, 2022 Director